Section
Industry
The cost of operating: establishment and reinspection fees, registration paperwork, and the payer rules that move with them.
-
Comment sought on the registration and fee paperwork for outsourcing facilities
A 60-day comment period opens on the information collection covering registration of human drug compounding outsourcing facilities and the fees associated with it.
-
Agency publishes the list of information collections cleared by the budget office
A routine notice setting out the information collections that the Office of Management and Budget has approved under the Paperwork Reduction Act of 1995.
-
Outsourcing facility establishment and reinspection fees set for fiscal 2027
The notice sets the annual establishment fee for small and non-small businesses, and the fee charged for each reinspection of an outsourcing facility, for the coming fiscal year.
-
Medication guides information collection sent for budget office review
The notice records that the proposed collection covering medication guides for prescription drug products has been submitted for review and clearance.
-
Medicare proposes to codify its drug price negotiation programme
The proposed rule would write the negotiation programme into regulation and set new policies for it and for the Medicare prescription drug benefit, including a change to the fixed combination drug policy.
-
Comment sought on the 503A and 503B compounding information collection
The agency opened a 60-day comment period on the information collection relating to human drug compounding under sections 503A and 503B of the Act.
-
Final rule revises Medicare Advantage and Part D for contract year 2027
The rule changes star ratings, marketing and communications, drug coverage, enrolment processes and special needs plan rules.
-
Compounding information collection submitted to the budget office for review
The agency recorded that the 503A and 503B human drug compounding information collection has gone to the Office of Management and Budget for review and clearance.